Status:
COMPLETED
Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate Biopsy
Lead Sponsor:
Heinrich-Heine University, Duesseldorf
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The hypothesis of the study is that targeted MRI/US fusion-guided prostate biopsy with additional systematic transrectal ultrasound (TRUS)-guided biopsy significantly detects more prostate cancers tha...
Detailed Description
In men with previously negative prostate biopsy and persistent elevated prostate-specific antigen (PSA) value, it is unclear which strategy offers the highest detection rate for prostate cancer. The h...
Eligibility Criteria
Inclusion
- At least one prior negative prostate biopsy
- Prostate-specific antigen (PSA) \> 4 ng/ml
Exclusion
- Known prostate cancer
- Contraindications against MRI
- Contraindications against prostate biopsy
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT02220517
Start Date
November 1 2011
End Date
October 1 2014
Last Update
March 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Düsseldorf
Düsseldorf, Germany, 40225